Skip to main content
Back to News

News From Around the System

Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes

UC San Diego Health — May 12, 2022

The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.

A New Way to Target Cancers Using 'Synthetic Lethality'

UC San Diego Health — May 12, 2022

Researchers at Ludwig Institute for Cancer Research and University of California San Diego School of Medicine report that inhibiting a key enzyme caused human cancer cells associated with two major types of breast and ovarian cancer to die and in mouse studies reduced tumor growth.

$55M NIH Grant Advances Clinical and Translational Research at UC San Diego

UC San Diego Health — May 12, 2022

The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.

3D 'Assembloid' Shows How SARS-CoV-2 Infects Brain Cells

UC San Diego Health — May 12, 2022

Researchers at UC San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus that causes COVID-19, into the human brain.

2VIDA! Tackles COVID Vaccine Hesitancy and Barriers in Latinx, Black Communities

UC San Diego Health — May 12, 2022

UC San Diego is collaborating with San Ysidro Health on an NIH-funded outreach program to address COVID-19 vaccine hesitancy in Latinx and African American communities. The team runs pop-up vaccination sites across San Diego, and goes door-to-door to homes and local businesses to spread awareness.

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts